Bharat Biotech had applied for approval for the emergency use of Covaxin in Nepal on 13 January.
Nepal Gives Approval to Bharat Biotech COVID Vaccine: The national drug regulator of Nepal has approved the emergency use of Bharat Biotech Vaccine Kovid-19 vaccine on Saturday. With this, it has become the third country to approve this vaccine made in India. According to the news of ‘Kathmandu Post’, a meeting of the Drug Advisory Committee of the Department of Drug Administration has decided to give conditional approval for the emergency use of COVAXIN. In the Phase III clinical trial in India, covaxine was found to be up to 81% effective.
Its use was approved in India in January. It was approved by Zimbabwe earlier this month. Bharat Biotech had applied for approval on 13 January in Nepal for emergency use of covaxine. The department approved the emergency use of the Oxford-AstraZeneca vaccine (Oxford Astrazeneca Vaccine) on 15 January. So far, a total of 275,750 cases of corona virus infection have been reported in Nepal. At the same time, 3,016 patients have died.
China’s vaccine has also been approved
Earlier on 17 February, Nepal had also approved emergency use of the BBIBP-CorV vaccine developed by China’s Sinopharm company. Nepal has also received one million doses of AstraZeneca vaccine from India. India has provided the vaccine to Nepal under its neighbor’s earlier policy. Now he is waiting to get another consignment of 20 lakh Kovid vaccine. This news related to the vaccine came after the authorities in Nepal had said that they are suspending the Vaccination Campaign due to low supply.
Zimbabwe also approved Chinese vaccine
In addition to India’s vaccine, Zimbabwe has also approved the Chinese Vaccine. It has received two lakh doses of China’s Kovid-19 vaccine sinoform. It is one of the first consignments of Chinese vaccines in Africa after Egypt and Equatorial Guinea. According to the country’s government media, in the first batch, the Sinofarm vaccine has been donated to China from this southern African country. The government of Emerson Manangagwa has also purchased an additional six lakh doses of the Sinopharm vaccine.
